222 related articles for article (PubMed ID: 14676834)
21. Regulation of the enzymatic function of the lymphocyte-specific tyrosine protein kinase p56lck by the non-catalytic SH2 and SH3 domains.
Veillette A; Caron L; Fournel M; Pawson T
Oncogene; 1992 May; 7(5):971-80. PubMed ID: 1570157
[TBL] [Abstract][Full Text] [Related]
22. Characterisation and chromosome mapping of the human non receptor tyrosine kinase gene, brk.
Mitchell PJ; Barker KT; Shipley J; Crompton MR
Oncogene; 1997 Sep; 15(12):1497-502. PubMed ID: 9333026
[TBL] [Abstract][Full Text] [Related]
23. SH2 domain-mediated interaction of inhibitory protein tyrosine kinase Csk with protein tyrosine phosphatase-HSCF.
Wang B; Lemay S; Tsai S; Veillette A
Mol Cell Biol; 2001 Feb; 21(4):1077-88. PubMed ID: 11158295
[TBL] [Abstract][Full Text] [Related]
24. Structural basis for domain-domain communication in a protein tyrosine kinase, the C-terminal Src kinase.
Lin X; Wang Y; Ahmadibeni Y; Parang K; Sun G
J Mol Biol; 2006 Apr; 357(4):1263-73. PubMed ID: 16483606
[TBL] [Abstract][Full Text] [Related]
25. The SH3 and SH2 domains are capable of directing specificity in protein interactions between the non-receptor tyrosine kinases cSrc and cYes.
Summy JM; Guappone AC; Sudol M; Flynn DC
Oncogene; 2000 Jan; 19(1):155-60. PubMed ID: 10644991
[TBL] [Abstract][Full Text] [Related]
26. Crosstalk between the catalytic and regulatory domains allows bidirectional regulation of Src.
Gonfloni S; Weijland A; Kretzschmar J; Superti-Furga G
Nat Struct Biol; 2000 Apr; 7(4):281-6. PubMed ID: 10742171
[TBL] [Abstract][Full Text] [Related]
27. Biochemical properties of the Cdc42-associated tyrosine kinase ACK1. Substrate specificity, authphosphorylation, and interaction with Hck.
Yokoyama N; Miller WT
J Biol Chem; 2003 Nov; 278(48):47713-23. PubMed ID: 14506255
[TBL] [Abstract][Full Text] [Related]
28. Sam68 associates with the SH3 domains of Grb2 recruiting GAP to the Grb2-SOS complex in insulin receptor signaling.
Najib S; Sánchez-Margalet V
J Cell Biochem; 2002; 86(1):99-106. PubMed ID: 12112020
[TBL] [Abstract][Full Text] [Related]
29. Cancer-Associated Mutations in Breast Tumor Kinase/PTK6 Differentially Affect Enzyme Activity and Substrate Recognition.
Tsui T; Miller WT
Biochemistry; 2015 May; 54(20):3173-82. PubMed ID: 25940761
[TBL] [Abstract][Full Text] [Related]
30. Cooperative activation of Src family kinases by SH3 and SH2 ligands.
Yadav SS; Miller WT
Cancer Lett; 2007 Nov; 257(1):116-23. PubMed ID: 17719722
[TBL] [Abstract][Full Text] [Related]
31. Involvement of STAP-2 in Brk-mediated phosphorylation and activation of STAT5 in breast cancer cells.
Ikeda O; Mizushima A; Sekine Y; Yamamoto C; Muromoto R; Nanbo A; Oritani K; Yoshimura A; Matsuda T
Cancer Sci; 2011 Apr; 102(4):756-61. PubMed ID: 21205088
[TBL] [Abstract][Full Text] [Related]
32. Intramolecular regulatory interactions in the Src family kinase Hck probed by mutagenesis of a conserved tryptophan residue.
LaFevre-Bernt M; Sicheri F; Pico A; Porter M; Kuriyan J; Miller WT
J Biol Chem; 1998 Nov; 273(48):32129-34. PubMed ID: 9822689
[TBL] [Abstract][Full Text] [Related]
33. Sik (BRK) phosphorylates Sam68 in the nucleus and negatively regulates its RNA binding ability.
Derry JJ; Richard S; Valderrama Carvajal H; Ye X; Vasioukhin V; Cochrane AW; Chen T; Tyner AL
Mol Cell Biol; 2000 Aug; 20(16):6114-26. PubMed ID: 10913193
[TBL] [Abstract][Full Text] [Related]
34. The unique N-terminal region of SRMS regulates enzymatic activity and phosphorylation of its novel substrate docking protein 1.
Goel RK; Miah S; Black K; Kalra N; Dai C; Lukong KE
FEBS J; 2013 Sep; 280(18):4539-59. PubMed ID: 23822091
[TBL] [Abstract][Full Text] [Related]
35. The nuclear tyrosine kinase BRK/Sik phosphorylates and inhibits the RNA-binding activities of the Sam68-like mammalian proteins SLM-1 and SLM-2.
Haegebarth A; Heap D; Bie W; Derry JJ; Richard S; Tyner AL
J Biol Chem; 2004 Dec; 279(52):54398-404. PubMed ID: 15471878
[TBL] [Abstract][Full Text] [Related]
36. Tandem SH2 binding sites mediate the RasGAP-RhoGAP interaction: a conformational mechanism for SH3 domain regulation.
Hu KQ; Settleman J
EMBO J; 1997 Feb; 16(3):473-83. PubMed ID: 9034330
[TBL] [Abstract][Full Text] [Related]
37. BRK phosphorylates PSF promoting its cytoplasmic localization and cell cycle arrest.
Lukong KE; Huot ME; Richard S
Cell Signal; 2009 Sep; 21(9):1415-22. PubMed ID: 19439179
[TBL] [Abstract][Full Text] [Related]
38. Tyrosine phosphorylation of sam68 by breast tumor kinase regulates intranuclear localization and cell cycle progression.
Lukong KE; Larocque D; Tyner AL; Richard S
J Biol Chem; 2005 Nov; 280(46):38639-47. PubMed ID: 16179349
[TBL] [Abstract][Full Text] [Related]
39. Structural basis of the auto-inhibition mechanism of nonreceptor tyrosine kinase PTK6.
Ko S; Ahn KE; Lee YM; Ahn HC; Lee W
Biochem Biophys Res Commun; 2009 Jun; 384(2):236-42. PubMed ID: 19401189
[TBL] [Abstract][Full Text] [Related]
40. Role of breast tumour kinase in the in vitro differentiation of HaCaT cells.
Wang TC; Jee SH; Tsai TF; Huang YL; Tsai WL; Chen RH
Br J Dermatol; 2005 Aug; 153(2):282-9. PubMed ID: 16086737
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
